A low dose of IGF2 (≤ 50 ng per mouse) alleviated colitis and inhibited inflammation, while high doses of IGF2 (1000 ng per mouse) failed to ameliorate colitis and instead exacerbated its progression and promoted inflammation (Wang et al. 2020). The gene discussed is IGF2; the disease is colitis.